The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease. [electronic resource]
Producer: 20010104Description: 235-45 p. digitalISSN:- 0014-4886
- 1-Methyl-4-phenylpyridinium -- pharmacokinetics
- Animals
- Antioxidants -- pharmacology
- Azoles -- pharmacology
- Behavior, Animal -- drug effects
- Blood Proteins -- pharmacology
- Callithrix
- Caudate Nucleus -- metabolism
- Disease Models, Animal
- Female
- Free Radicals -- metabolism
- Glutathione Peroxidase -- metabolism
- Herbicides -- pharmacokinetics
- Isoindoles
- Locomotion -- drug effects
- Male
- Mitochondria -- drug effects
- Molecular Mimicry
- Neurons -- cytology
- Neuroprotective Agents -- pharmacology
- Organoselenium Compounds -- pharmacology
- PC12 Cells
- Parkinsonian Disorders -- drug therapy
- Rats
- Rats, Sprague-Dawley
- Substantia Nigra -- metabolism
- Tritium
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.